Introducing MDR: Faster Access to EU Markets, Without the Bottlenecks

May 14, 2026 | News

Guideways announces the full availability of its EU MDR~ AI agents

Bringing products to the European market is full of opportunity but also complexity. Navigating regulatory requirements, preparing documentation, and ensuring submission quality can slow even the most experienced teams down.

If you’re looking to accelerate EU market access, reduce regulatory bottlenecks, and improve submission confidence, now’s the time to explore what’s possible.

A Smarter Way to Enter Markets

Both Guideways Sherpa and Researcher AI agents now come built in with MDR support. Our agents were built to help regulatory and product teams move faster through the FDA and MDR approval process without compromising on quality or compliance. 

Navigate EU regulations with clarity
Understanding and applying EU requirements can be time-consuming. Sherpa helps you interpret what’s needed and guides you through the process, reducing uncertainty and back-and-forth.

Improve submission quality
Better inputs lead to better outcomes. Reviewer helps ensure your submissions are complete, consistent, and aligned with expectations, reducing the risk of delays.

Reduce time to market
By removing bottlenecks and improving efficiency our agents help you move from development to approval faster so you can start delivering value in EU markets sooner.

 

Built for Teams That Need to Move Fast

Dozens of companies are already using our platform to reduce regulatory friction and speed up approvals. With Guideways AI agents for MDR we’re taking that a step further: unlocking faster, more confident access to EU markets.

Get started with Guideways or book a demo to see how it works for your team.